» Articles » PMID: 18562055

Osteoradionecrosis of the Jaws: Current Understanding of Its Pathophysiology and Treatment

Overview
Date 2008 Jun 20
PMID 18562055
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

During the past 80 years a number of theories about the pathogenesis of osteoradionecrosis (ORN) have been proposed, with consequent implications for its treatment. Until recently tissue hypoxia and its consequences were accepted as the primary cause, and this led to the use of hyperbaric oxygen (HBO) for both treatment and prevention of complications of radiotherapy in the head and neck. The benefit of HBO has not been validated. A new theory for the pathogenesis of ORN has proposed that damage to bone is caused by radiation-induced fibrosis. Cells in bone are damaged as a result of acute inflammation, free radicals, and the chronic activation of fibroblasts by a series of growth factors. New treatments have therefore been devised that include pentoxifylline, a vasodilator that also inhibits fibrosis, and tocopherol (vitamin E) to reduce damage caused by free radicals. Impressive results in terms of reversing the process of ONR have been reported using these agents. It has been suggested that this theory and these agents could be the basis of future treatment and prevention of ORN.

Citing Articles

Identification and management of recurrent oral squamous cell carcinoma in the clinical presentation of osteoradionecrosis: a single-center case series for treatment experience sharing.

Zhang S, Mao L, Yu Z, Li J, Ma S, Jia J BMC Oral Health. 2025; 25(1):228.

PMID: 39948512 PMC: 11827261. DOI: 10.1186/s12903-025-05603-4.


Utility of lymphocyte-to-monocyte ratio and pretreatment tooth extraction in intra-arterial chemoradiotherapy for oral cancer to prevent osteoradionecrosis of the jaw.

Kubota K, Furudate K, Ito R, Narita N, Tanaka Y, Tamura Y Sci Rep. 2024; 14(1):30892.

PMID: 39730743 PMC: 11681047. DOI: 10.1038/s41598-024-81766-4.


Proactive Customized Protocol for Oral Management in Head and Neck Cancer Patients Planned for Radiotherapy.

Kenkere D, Gudibande M, Deepa C, Srinath K, Harshitha K, Reddy M J Maxillofac Oral Surg. 2024; 23(6):1366-1370.

PMID: 39618433 PMC: 11607274. DOI: 10.1007/s12663-021-01511-6.


[ glycopeptide reduces bone loss caused by exosomes derived from human gingival fibroblasts with radiation exposure].

He S, Wen N, Chen X, Wang Y, Zhang T, Mu Y Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(9):1752-1759.

PMID: 39505343 PMC: 11744091. DOI: 10.12122/j.issn.1673-4254.2024.09.15.


Relationship between bone union and degree of bone marrow fibrosis at resection margins of advanced mandibular ORN.

Ohori H, Iwata E, Ichikawa C, Shigeoka M, Tadokoro Y, Takeda D Clin Oral Investig. 2024; 28(11):626.

PMID: 39496886 PMC: 11534885. DOI: 10.1007/s00784-024-06008-3.